Search
for
Sort by
Research 61–90 of 280
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- COVID‐19, androgens, and androgenic alopecia
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Androgen deprivation therapy and hormonal status in men with COVID-19
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Androgens in SARS-CoV-2 Coronavirus Infections
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Dermatological Manifestations of COVID-19: A Brief Review
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Diet and hair loss: effects of nutrient deficiency and supplement use
- Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment
- Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium
- Obstructive sleep apnea, low transferrin saturation levels, and male‐pattern baldness
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Insights into disparities observed with COVID‐19
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels